摘要
目的 探讨膜性布 加综合征的最佳治疗方法。方法 对 480例膜性布 加综合征患者手术的长期疗效和复发情况进行回顾性分析。结果 破膜组 5 2例 ,随访率 84 6 2 % (4 4/ 5 2 ) ,随访时间 6个月至 10年 ,有效率 6 1 4% ,复发率 38 6 %。介入组 2 38例 ,随访率 86 5 5 % (2 0 6 / 2 38) ,随访时间6个月至 8年 ,有效率 91 7% ;复发 17例 ,复发率 8 3%。根治组 190例 ,随访率 87 37% (16 6 / 190 ) ,随访时间 9个月至 8年 ,有效率 90 4% ,复发率 9 6 %。介入组、根治组的长期效果明显优于破膜组(P <0 0 5 ) ,复发率低于破膜组 (P <0 0 5 )。结论 膜性布 加综合征患者治疗应首选介入球囊扩张术 ,对于病变范围大、膜厚和介入治疗后复发的病例 。
ObjectiveTo explore the best therapy for the treatment of membranous Budd-Chiari syndrome.MethodsThe surgical result of 480 cases with membranous Budd-Chiari syndrome was analysed retrospectively.ResultsCases of Kimura′s finger rupture, interventional treatment and membrane resection were followed up, with follow-up rates of 84.62%, 86.55% and 87.37% respectively, with effective rates of 61.4%, 91.7% and 90.4% respectively, recurrence rates of 38.6%, 8.3% and 9.6% respectively. The long-term effect of interventional treatment and resection was significantly better than Kimura′s finger rupture(P<0.05). ConclusionsBalloon dilatation is the therapy of choice for membranous Budd-Chiari syndrome. Cases with extensive lesion, thick membranes or recurrence after PTA should undergo membrane resection.
出处
《中华普通外科杂志》
CSCD
北大核心
2002年第11期654-656,共3页
Chinese Journal of General Surgery
